Status:
COMPLETED
Safety and Efficacy of AAE581 in Postmenopausal Women With Osteoporosis
Lead Sponsor:
Novartis Pharmaceuticals
Conditions:
Osteoporosis
Eligibility:
FEMALE
50-75 years
Phase:
PHASE2
Brief Summary
This study will test the safety and efficacy of AAE581 in increasing Lumbar Spine bone mineral density (BMD) at 12 months, by Dexa-scan (DXA) in postmenopausal women with osteoporosis.
Eligibility Criteria
Inclusion
- BMD T Score between -2 to -3.5
- 50-75 years old
Exclusion
- Urolithiasis
- Bisphosphonates
- Other protocol-defined inclusion/exclusion criteria may apply.
Key Trial Info
Start Date :
February 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2005
Estimated Enrollment :
676 Patients enrolled
Trial Details
Trial ID
NCT00100607
Start Date
February 1 2004
End Date
September 1 2005
Last Update
May 8 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.